Department of Microbiology and Immunology, McGill University, Montréal, QC.
Immunology. 2009 Dec;128(4):534-42. doi: 10.1111/j.1365-2567.2009.03139.x.
Protein tyrosine phosphorylation is an important early event in the signal transduction of numerous cell receptors involved in the immune response. The implication of protein tyrosine kinases in allergic asthma is well recognized, but the role of protein tyrosine phosphatases (PTPs) remains poorly understood. However, we recently reported that global inhibition of PTPs during either the allergen-sensitization phase or the allergen-challenge phase reduced the development of asthma and that this correlated with an increased T helper 1 (Th1) response in both lung and spleen tissues. Therefore, in this study we investigated individual roles of PTPs involved in regulating the immune response. We observed that genetic deficiency for PTP-1B resulted in increased recruitment of lung inflammatory cells, while protein tyrosine phosphatase-phosphatase and tensin homologue deleted (PTP-PEST)-deficient mice exhibited a phenotype similar to that of wild-type mice. Importantly, we found that a heterozygous mutation of T cell PTP (TC-PTP) dramatically abrogates immunoglobulin E production and reduces the recruitment of inflammatory cells to the lung, conferring an important role for TC-PTP in the development of allergic asthma. As opposed to other studies on Src homology phosphatase-1 (SHP-1) deficiency, specific acute SHP-1 inhibition during allergen challenge did not affect disease outcome. Collectively, our results underscore the importance of PTPs in the development of allergic asthma.
蛋白质酪氨酸磷酸化是许多参与免疫反应的细胞受体信号转导中的一个重要早期事件。蛋白质酪氨酸激酶在过敏性哮喘中的作用已得到充分认识,但蛋白质酪氨酸磷酸酶(PTPs)的作用仍知之甚少。然而,我们最近报道称,在过敏原致敏阶段或过敏原挑战阶段,抑制 PTPs 的全局表达可减少哮喘的发展,这与肺和脾组织中 Th1 反应的增加有关。因此,在这项研究中,我们研究了参与调节免疫反应的 PTP 的个体作用。我们观察到,PTP-1B 的遗传缺陷导致肺炎症细胞的募集增加,而蛋白酪氨酸磷酸酶-磷酸酶和张力蛋白同源物缺失(PTP-PEST)缺陷小鼠表现出与野生型小鼠相似的表型。重要的是,我们发现 T 细胞 PTP(TC-PTP)的杂合突变显著阻断了免疫球蛋白 E 的产生,并减少了炎症细胞向肺部的募集,这表明 TC-PTP 在过敏性哮喘的发展中具有重要作用。与其他关于Src 同源性磷酸酶-1(SHP-1)缺陷的研究相反,在过敏原挑战期间特异性急性 SHP-1 抑制并不影响疾病结局。总的来说,我们的研究结果强调了 PTPs 在过敏性哮喘发展中的重要性。